nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—ADRA1B—polycystic ovary syndrome	0.529	0.598	CbGaD
Dextroamphetamine—ADRA1A—polycystic ovary syndrome	0.356	0.402	CbGaD
Dextroamphetamine—Mephentermine—ADRA1A—polycystic ovary syndrome	0.000912	0.162	CrCbGaD
Dextroamphetamine—Lisdexamfetamine—ADRA1B—polycystic ovary syndrome	0.000906	0.161	CrCbGaD
Dextroamphetamine—L-Phenylalanine—TH—polycystic ovary syndrome	0.000598	0.106	CrCbGaD
Dextroamphetamine—Tolazoline—ADRA1A—polycystic ovary syndrome	0.00049	0.0871	CrCbGaD
Dextroamphetamine—Ephedrine—ADRA1A—polycystic ovary syndrome	0.000477	0.0849	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRA1A—polycystic ovary syndrome	0.000428	0.0761	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRA1A—polycystic ovary syndrome	0.000362	0.0643	CrCbGaD
Dextroamphetamine—Ephedrine—ADRB2—polycystic ovary syndrome	0.000284	0.0505	CrCbGaD
Dextroamphetamine—Benzphetamine—ADRA1A—polycystic ovary syndrome	0.00027	0.048	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRB2—polycystic ovary syndrome	0.000254	0.0453	CrCbGaD
Dextroamphetamine—Nateglinide—PPARG—polycystic ovary syndrome	0.000238	0.0424	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRB2—polycystic ovary syndrome	0.000215	0.0383	CrCbGaD
Dextroamphetamine—Benzyl alcohol—CYP1A1—polycystic ovary syndrome	0.000188	0.0334	CrCbGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTGER3—polycystic ovary syndrome	6.36e-05	0.00058	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—LHCGR—polycystic ovary syndrome	6.36e-05	0.00058	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	6.35e-05	0.00058	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	6.26e-05	0.000571	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PLAT—polycystic ovary syndrome	6.24e-05	0.000569	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GHRL—polycystic ovary syndrome	6.24e-05	0.000569	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	6.22e-05	0.000567	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	6.22e-05	0.000567	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	6.12e-05	0.000558	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	6.07e-05	0.000554	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—POMC—polycystic ovary syndrome	6.01e-05	0.000548	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.96e-05	0.000544	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ATF1—polycystic ovary syndrome	5.95e-05	0.000543	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTAFR—polycystic ovary syndrome	5.94e-05	0.000542	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	5.87e-05	0.000535	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	5.81e-05	0.000531	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.8e-05	0.00053	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.78e-05	0.000527	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	5.77e-05	0.000527	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	5.77e-05	0.000527	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	5.66e-05	0.000516	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	5.64e-05	0.000515	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	5.64e-05	0.000515	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	5.64e-05	0.000515	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	5.62e-05	0.000513	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	5.62e-05	0.000513	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NGFR—polycystic ovary syndrome	5.49e-05	0.000501	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	5.49e-05	0.000501	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—POMC—polycystic ovary syndrome	5.46e-05	0.000498	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PRL—polycystic ovary syndrome	5.44e-05	0.000497	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	5.28e-05	0.000482	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.25e-05	0.000479	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.22e-05	0.000477	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—GHRL—polycystic ovary syndrome	5.21e-05	0.000475	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.16e-05	0.000471	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FLT4—polycystic ovary syndrome	5.15e-05	0.00047	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	5.13e-05	0.000468	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—FSHR—polycystic ovary syndrome	5.12e-05	0.000467	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PDE3B—polycystic ovary syndrome	5.11e-05	0.000466	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	5.1e-05	0.000466	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	5.03e-05	0.000459	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	5.03e-05	0.000459	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	5e-05	0.000456	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	4.99e-05	0.000455	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	4.98e-05	0.000454	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—GNAS—polycystic ovary syndrome	4.79e-05	0.000437	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.78e-05	0.000436	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	4.68e-05	0.000428	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—FSHR—polycystic ovary syndrome	4.65e-05	0.000424	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	4.63e-05	0.000422	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	4.62e-05	0.000422	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FLT4—polycystic ovary syndrome	4.57e-05	0.000417	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.56e-05	0.000416	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	4.55e-05	0.000415	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	4.54e-05	0.000414	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	4.51e-05	0.000412	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NPB—polycystic ovary syndrome	4.5e-05	0.00041	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NRG1—polycystic ovary syndrome	4.48e-05	0.000409	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—LHB—polycystic ovary syndrome	4.46e-05	0.000407	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	4.36e-05	0.000397	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—ADRB2—polycystic ovary syndrome	4.31e-05	0.000393	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	4.25e-05	0.000388	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	4.23e-05	0.000386	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—SCT—polycystic ovary syndrome	4.18e-05	0.000381	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	4.13e-05	0.000377	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	4.11e-05	0.000375	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADRB3—polycystic ovary syndrome	4.1e-05	0.000374	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	4.07e-05	0.000371	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	4.06e-05	0.00037	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—LHB—polycystic ovary syndrome	4.05e-05	0.000369	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.01e-05	0.000366	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	4.01e-05	0.000366	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—GNAS—polycystic ovary syndrome	4e-05	0.000365	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	4e-05	0.000365	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	3.98e-05	0.000364	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	3.96e-05	0.000361	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GNRH1—polycystic ovary syndrome	3.96e-05	0.000361	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	3.87e-05	0.000353	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IRS2—polycystic ovary syndrome	3.84e-05	0.00035	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	3.83e-05	0.000349	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—SCT—polycystic ovary syndrome	3.79e-05	0.000346	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.75e-05	0.000343	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.75e-05	0.000343	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—LEP—polycystic ovary syndrome	3.75e-05	0.000342	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	3.71e-05	0.000338	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	3.64e-05	0.000332	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	3.62e-05	0.00033	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.62e-05	0.00033	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	3.61e-05	0.00033	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	3.59e-05	0.000328	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	3.55e-05	0.000324	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	3.55e-05	0.000324	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	3.54e-05	0.000323	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.53e-05	0.000322	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	3.51e-05	0.000321	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.51e-05	0.00032	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.41e-05	0.000311	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	3.37e-05	0.000307	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IRS1—polycystic ovary syndrome	3.35e-05	0.000306	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	3.33e-05	0.000304	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	3.33e-05	0.000304	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	3.31e-05	0.000302	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	3.31e-05	0.000302	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—INHBB—polycystic ovary syndrome	3.23e-05	0.000295	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—POMC—polycystic ovary syndrome	3.22e-05	0.000294	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	3.21e-05	0.000293	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—INS—polycystic ovary syndrome	3.21e-05	0.000293	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	3.14e-05	0.000286	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	3.12e-05	0.000285	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.1e-05	0.000283	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.1e-05	0.000283	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	3.08e-05	0.000281	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	3.07e-05	0.00028	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	3.03e-05	0.000276	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.02e-05	0.000275	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	2.95e-05	0.000269	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.95e-05	0.000269	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.94e-05	0.000268	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	2.87e-05	0.000262	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FSHR—polycystic ovary syndrome	2.75e-05	0.000251	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—POMC—polycystic ovary syndrome	2.69e-05	0.000246	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	2.68e-05	0.000245	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.67e-05	0.000244	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	2.62e-05	0.000239	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	2.62e-05	0.000239	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	2.61e-05	0.000238	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.58e-05	0.000236	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.51e-05	0.000229	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FST—polycystic ovary syndrome	2.45e-05	0.000223	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	2.44e-05	0.000223	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.44e-05	0.000222	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.42e-05	0.000221	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LHB—polycystic ovary syndrome	2.39e-05	0.000218	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	2.39e-05	0.000218	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	2.37e-05	0.000217	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.37e-05	0.000216	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.34e-05	0.000213	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.29e-05	0.000209	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.26e-05	0.000206	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.26e-05	0.000206	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SCT—polycystic ovary syndrome	2.24e-05	0.000204	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.21e-05	0.000202	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.19e-05	0.0002	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	2.18e-05	0.000199	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.16e-05	0.000197	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.15e-05	0.000196	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.14e-05	0.000195	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.12e-05	0.000194	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGF18—polycystic ovary syndrome	2.1e-05	0.000192	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RBP4—polycystic ovary syndrome	2.08e-05	0.00019	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.08e-05	0.00019	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.08e-05	0.000189	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.07e-05	0.000189	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.05e-05	0.000187	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.03e-05	0.000185	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.01e-05	0.000183	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.01e-05	0.000183	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	1.99e-05	0.000182	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	1.98e-05	0.000181	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	1.96e-05	0.000179	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—YAP1—polycystic ovary syndrome	1.94e-05	0.000177	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GAB1—polycystic ovary syndrome	1.92e-05	0.000175	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	1.9e-05	0.000173	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	1.87e-05	0.00017	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	1.85e-05	0.000169	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	1.84e-05	0.000168	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—INSR—polycystic ovary syndrome	1.83e-05	0.000167	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	1.82e-05	0.000166	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.77e-05	0.000161	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.74e-05	0.000159	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	1.73e-05	0.000158	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.71e-05	0.000156	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PGR—polycystic ovary syndrome	1.7e-05	0.000155	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.69e-05	0.000154	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	1.63e-05	0.000149	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLAT—polycystic ovary syndrome	1.58e-05	0.000144	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GHRL—polycystic ovary syndrome	1.58e-05	0.000144	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.55e-05	0.000141	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.54e-05	0.00014	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.52e-05	0.000139	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.52e-05	0.000139	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	1.51e-05	0.000138	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ATF1—polycystic ovary syndrome	1.51e-05	0.000137	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.5e-05	0.000137	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.47e-05	0.000134	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.46e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.46e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.4e-05	0.000128	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.4e-05	0.000128	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—polycystic ovary syndrome	1.4e-05	0.000128	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NGFR—polycystic ovary syndrome	1.39e-05	0.000127	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—polycystic ovary syndrome	1.38e-05	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRL—polycystic ovary syndrome	1.38e-05	0.000126	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.35e-05	0.000123	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.34e-05	0.000122	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.34e-05	0.000122	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.33e-05	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.31e-05	0.000119	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.3e-05	0.000119	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.3e-05	0.000118	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.3e-05	0.000118	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.25e-05	0.000114	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.23e-05	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.23e-05	0.000112	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.22e-05	0.000112	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.21e-05	0.000111	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.2e-05	0.00011	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.19e-05	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.18e-05	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.16e-05	0.000106	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.15e-05	0.000105	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.13e-05	0.000103	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.12e-05	0.000102	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.1e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.08e-05	9.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.02e-05	9.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.01e-05	9.18e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	9.7e-06	8.85e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	9.54e-06	8.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	9.49e-06	8.66e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	9.28e-06	8.47e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	8.73e-06	7.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.62e-06	7.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	8.47e-06	7.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	8.43e-06	7.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	8.16e-06	7.44e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	8.11e-06	7.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	7.85e-06	7.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	7.84e-06	7.15e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	7.79e-06	7.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.52e-06	6.87e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.45e-06	6.8e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	7.42e-06	6.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	7.24e-06	6.61e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	7.2e-06	6.57e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	7.04e-06	6.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.97e-06	6.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.96e-06	6.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.62e-06	6.04e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.56e-06	5.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	6e-06	5.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.33e-06	4.86e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.32e-06	4.85e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.25e-06	4.79e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.22e-06	4.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.12e-06	4.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.55e-06	4.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	3.54e-06	3.23e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	3.15e-06	2.87e-05	CbGpPWpGaD
